Parallax Volatility Advisers, L.P. Protagonist Therapeutics, Inc Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$6.3 - $10.44 $119 - $198	-19 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.82 - $11.26 $129 - $213	19 New	19 $0
Q1 2018 May 15, 2018	SELL	$8.46 - $23.08 $12,080 - $32,958	-1,428 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.47 - $20.8 $20,663 - $29,702	1,428	1,428 $30,000

254

58.9M

226K

218K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.85B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.